Metilprednizolon Teva

Methylprednisolone Sodium Succinate, the active ingredient in Metilprednizolon Teva, is a glucocorticoid presented as an injectable solution for intravenous use. It is employed to treat acute exacerbations of asthma and chronic obstructive pulmonary disease, severe allergic reactions, rheumatic and musculoskeletal disorders, autoimmune diseases, adrenal insufficiency, and to prevent postoperative inflammation.

GNH USA supplies Metilprednizolon Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metilprednizolon Teva, a systemic glucocorticoid, is indicated for several inflammatory and immune‑mediated conditions.

- Acute asthma and COPD exacerbations: rapidly reduces airway inflammation and improves airflow. - Severe allergic reactions (e.g., anaphylaxis): suppresses mast‑cell mediator release and stabilises the immune response. - Rheumatic and musculoskeletal disorders: diminishes joint inflammation and pain. - Autoimmune diseases: modulates immune activity to control disease flares. - Postoperative inflammation prevention: limits surgical tissue swelling and pain.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Increased blood glucose levels. - Fluid retention and peripheral edema. - Elevated blood pressure. - Mood changes such as anxiety or insomnia. - Increased appetite and weight gain. - Gastro‑intestinal discomfort.

Serious or Rare Side Effects: - Severe infections due to immunosuppression. - Adrenal insufficiency on abrupt discontinuation. - Gastro‑intestinal bleeding or ulceration. - Anaphylactic or severe hypersensitivity reactions. - Psychosis or severe mood disturbances. - Osteonecrosis of the femoral head.

Careful assessment and monitoring are required before and during therapy. - Infection risk: evaluate for active infections and avoid unnecessary exposure. - Glucose monitoring: patients with diabetes need regular blood‑sugar checks. - Cardiovascular status: monitor blood pressure and fluid balance. - Bone health: consider prophylaxis for osteoporosis in long‑term use. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Methylprednisolone can alter the effects of several concomitant medicines.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase steroid exposure. - Live vaccines: risk of uncontrolled infection. - NSAIDs: heightened risk of gastrointestinal bleeding. - Anticoagulants: enhanced anticoagulant effect. - Diuretics: may exacerbate potassium loss.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may reduce steroid efficacy. - Antidiabetic agents: possible hyperglycaemia, adjust dose as needed. - Antihypertensives: steroid‑induced fluid retention may blunt response. - Non‑live vaccines: monitor immune response. - Other immunosuppressants: cumulative immunosuppression risk.